UHC, Cigna and Centene Sign On to New National Shared Credentialing Program
CertifyOS launched a shared credentialing program that allows providers to submit their information once for…
UHC, Cigna and Centene Sign On to New National Shared Credentialing Program
CertifyOS launched a shared credentialing program that allows providers to submit their information once for multiple health plans. The post UHC, Cigna and Centene Sign On to New National Shared Credentialing Program appeared first on MedCity News.
Lilly Again Looks to China for New Drugs, Paying InnoCare $100M to Start R&D Pact
Eli Lilly’s partnership with InnoCare Pharma follows deals struck this year with other China-based companies. While indications for the new alliance remain undisclosed, InnoCare specializes in oncology and autoimmune drugs. The post Lilly Again Looks to China for New Drugs, Paying InnoCare $100M to Start R&D Pact appeared first on MedCity News.
Athenahealth Adding Value-Based Care Tools to EHR
A Data Explorer tool helps clinical and administrative teams monitor performance against quality measures and identify care gaps
From OpenNotes to “Doc Can I Record You?” Why Physicians Should Embrace Era of Accountability
Healthcare has a habit of embracing patient empowerment right up until patients become powerful. The post From OpenNotes to “Doc Can I Record You?” Why Physicians Should Embrace Era of Accountability appeared first on MedCity News.
Merlino to Succeed Perlin at Helm of Joint Commission
Prior to the Joint Commission, Merlino served as chief clinical transformation officer at Cleveland Clinic
Modernizing Medicare Advantage for the Next Generation of Seniors
The Centers for Medicare & Medicaid Services (CMS) took constructive steps in its 2027 final rule and rate announcement, particularly on payment integrity and quality measurement. But those steps are not the finish line. Policymakers should further modernize MA to strengthen competition, transparency and accountability. Here’s where to start. The post Modernizing Medicare Advantage for…
OHSU’s Bill Hersh, M.D., to Receive AMIA’s Collen Award
Informatics leader conceptualized and implemented the first offering of the AMIA 10×10 program
How TrumpRx Brand-Name Drug Prices Compare to Other Countries
TrumpRx prices for brand-name drugs are about as likely to be higher as lower compared to average prices in other wealthy countries, according to an analysis that compares 32 brand-name drugs (without generics or biosimilars) on the TrumpRx website with publicly available prices in one or more of 11 OECD member countries.
Analysis: Prices for Many Brand-Name TrumpRx Drugs Are Cheaper than the Average Price in Other Wealthy Countries, But Are Almost as Likely To Be More Expensive
Consumers who buy brand-name prescription drugs without an available generic or biosimilar at the prices available through the new TrumpRx website are about as likely to pay more as pay less for those drugs relative to the publicly listed prices available in other comparatively wealthy countries, a new KFF analysis finds.
KFF Women’s Health Survey Explores How Women Navigate Contraceptive Information — The Monitor
Many reproductive-age women seek health information through online sources, where they may encounter false or misleading information about contraception, according to the 2026 KFF Women’s Health Survey. And an Ohio health department’s new AI policy offers a rare example of a health-specific policy addressing accuracy and public trust.
